galantamine has been researched along with Long Sleeper Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, M; Murata, T | 1 |
| Bozoglu, E; Cintosun, U; Doruk, H; Kocak, N; Naharci, MI; Ozturk, A; Tasci, I; Yasar, H | 1 |
| Lewis, SJ; Szeto, JY | 1 |
| Chankrachang, S; Nidhinandana, S; Phanthumchinda, K; Poungvarin, N; Praditsuwan, R; Senanarong, V; Tavichachart, N | 1 |
| Ishida, T; Kamei, C | 1 |
| Hirase, M; Ishida, T; Kamei, C; Takeda, Y | 1 |
| Krasakov, IV; Litvinenko, IV; Tikhomirova, OV | 1 |
| Gutterman, EM; Lilienfeld, S; Markowitz, JS; Papadopoulos, G | 1 |
| Markowitz, JS; Papadopoulos, G; Sadik, K; Stahl, SM | 1 |
| Herrmann, N; Lanctôt, KL; Thompson, S | 1 |
| Borson, S; Kaufer, DI; Kershaw, P; Sadik, K | 1 |
| Ancoli-Israel, S; Cooke, JR; Corey-Bloom, J; Fiorentino, L; Harrison, T; Liu, L; Loredo, JS; Marler, M | 1 |
| Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G | 1 |
| Backhaus, J; Berger, M; Ebert, D; Faulmann, A; Gann, HJ; Hohagen, F; Hornyak, M; Kiemen, A; Klein, T; Riemann, D; Voderholzer, U | 1 |
3 review(s) available for galantamine and Long Sleeper Syndrome
| Article | Year |
|---|---|
Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.
Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Exercise Therapy; Galantamine; Humans; Indans; Memantine; Parkinson Disease; Piperidines; Rivastigmine; Sleep Wake Disorders; Treatment Outcome | 2016 |
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome | 2004 |
Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine.
Topics: Aged; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cost of Illness; Depression; Employment; Galantamine; Humans; Sleep Wake Disorders | 2005 |
4 trial(s) available for galantamine and Long Sleeper Syndrome
| Article | Year |
|---|---|
Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Drug Administration Schedule; Female; Galantamine; Humans; Male; Prevalence; Severity of Illness Index; Sleep Wake Disorders | 2003 |
Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Polysomnography; Rivastigmine; Sleep Stages; Sleep Wake Disorders | 2006 |
Cholinergic neurotransmission, REM sleep and depression.
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine | 1994 |
Sleep and the cholinergic rem sleep induction test in patients with primary alcoholism.
Topics: Adult; Alcoholism; Cholinesterase Inhibitors; Double-Blind Method; Female; Galantamine; Humans; Male; Polysomnography; Sleep Wake Disorders; Sleep, REM | 1998 |
7 other study(ies) available for galantamine and Long Sleeper Syndrome
| Article | Year |
|---|---|
Lemborexant add-on further improves the effect of galantamine on sleep-wake disorder in Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Pyridines; Pyrimidines; Sleep; Sleep Wake Disorders | 2022 |
Galantamine improves sleep quality in patients with dementia.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Indans; Male; Piperidines; Rivastigmine; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome | 2015 |
The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
Topics: Aged; Alzheimer Disease; Case-Control Studies; Cholinesterase Inhibitors; Female; Galantamine; Health Status Indicators; Humans; Male; Risk Factors; Sleep; Sleep Wake Disorders; Thailand | 2008 |
Characteristic effects of anti-dementia drugs on rat sleep patterns.
Topics: Animals; Dementia; Donepezil; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Excitatory Amino Acid Antagonists; Galantamine; Indans; Male; Memantine; Nootropic Agents; Piperidines; Rats; Rats, Wistar; Sleep; Sleep Wake Disorders; Sleep, REM | 2009 |
[Effects of anti-dementia drugs on sleep-wake patterns in sleep-disturbed rats].
Topics: Animals; Donepezil; Galantamine; Indans; Male; Nootropic Agents; Piperidines; Piracetam; Rats; Rats, Wistar; Sleep; Sleep Wake Disorders; Wakefulness | 2009 |
[Sleep disorders in patients with dementia in Parkinson's disease].
Topics: Aged; Dementia; Female; Galantamine; Humans; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders; Sleep, REM | 2011 |
Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dreams; Galantamine; Humans; Nootropic Agents; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders | 2004 |